[Helicobacter pylori and non-steroidal anti-inflammatory agents].

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Acta Medica Austriaca

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 10989682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.

  1999cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999cited by this paper
• Helicobacter pylori, NSAIDs and cognitive dissonance

  1999cited by this paper
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

  1999cited by this paper
• Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

  1999cited by this paper
• Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs).

  1999cited by this paper
• Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.

  1998cited by this paper
• Does eradication of Helicobacter pylori impair healing of nonsteroidal anti‐inflammatory drug associated bleeding peptic ulcers? A prospective randomized study

  1998cited by this paper
• Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently

  1998cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.

  1998cited by this paper
• Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer.

  1998cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.

  1996cited by this paper
• Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

  1993cited by this paper

• Pharmacoepidemiology and drug safety.

  2001cites this paper